Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Viral Hepat ; 18(9): 637-45, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21794025

RESUMEN

Hepatitis B virus (HBV) DNA levels and liver histological necroinflammation grades are correlated with the antiviral efficacy. It is necessary to clarify the relationship between HBV replication levels apportioned by the same hepatic parenchyma cell volume and severity of liver histological necroinflammation grades in both hepatitis B e antigen (HBeAg)-positive and HBeAg-negative chronic hepatitis B. The serum HBV DNA levels apportioned by the same hepatic parenchyma cell volume were compared between HBeAg-positive and HBeAg-negative chronic hepatitis B as well as among liver histological necroinflammation grades 1, 2, 3 and 4, respectively. There were no differences in the serum HBV DNA levels between HBeAg-positive and HBeAg-negative chronic hepatitis B as well as among liver histological necroinflammation grades 1, 2, 3 and 4. However, there were differences in the serum HBV DNA levels apportioned by the same hepatic parenchyma cell volume among liver histological necroinflammation grades 1, 2, 3 and 4 in both HBeAg-positive and HBeAg-negative chronic hepatitis B, respectively. There were no differences in HBV DNA levels with the same liver histological necroinflammation grade activated by HBV wild-type and variant strains. After the differences in hepatic parenchyma cell volume for HBV replication of the same liver histological necroinflammation grade accompanied by different hepatic fibrosis stages were adjusted, the serum HBV DNA level apportioned by the same hepatic parenchyma cell volume was correlated with the severity of liver histological necroinflammation grade.


Asunto(s)
ADN Viral/sangre , Virus de la Hepatitis B/patogenicidad , Hepatitis B Crónica/patología , Cirrosis Hepática/patología , Hígado/patología , Adulto , Alanina Transaminasa/sangre , Análisis de Varianza , Biopsia , Tamaño de la Célula , Femenino , Antígenos e de la Hepatitis B/sangre , Virus de la Hepatitis B/fisiología , Hepatitis B Crónica/virología , Humanos , Inflamación/patología , Inflamación/virología , Hígado/virología , Cirrosis Hepática/virología , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Replicación Viral , Adulto Joven
2.
Biochem Pharmacol ; 61(11): 1439-48, 2001 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-11331080

RESUMEN

It has been reported that an extract from Angelica sinensis mainly consisting of polysaccharides (95%) prevented ethanol- or indomethacin-induced gastric mucosal damage (Cho CH et al. Planta Med 2000;66:348-51). However, it is not known whether Angelica sinensis has a direct stimulatory effect on the healing of gastric mucosal lesions. To study the hypothesis that Angelica sinensis has a direct mucosal healing effect in rats and in isolated gastric epithelial cells, we assessed the wound repair in both animals and normal cell culture (RGM-1), as well as [3H]thymidine incorporation, ornithine decarboxylase (ODC) activity, and ODC protein and c-Myc protein expression after different treatments in RGM-1 cells. We found that Angelica sinensis crude extract (ASCE) dose-dependently enhanced gastric ulcer healing in rats and promoted wound repair in RGM-1 cells. It also significantly stimulated [3H]thymidine incorporation and ODC activity in RGM-1 cells in a concentration-dependent manner. ODC and c-Myc protein expression was also increased as a result of this process. DL-alpha-difluoromethyl-ornithine repressed the [3H]thymidine incorporation and ODC activity induced by ASCE. Pretreatment with c-Myc antisense oligodeoxynucleotides blocked the stimulatory action of ASCE on [3H]thymidine incorporation and ODC protein expression. These data suggest that ASCE has a direct mucosal healing effect on gastric epithelial cells, while ODC and c-Myc are closely associated with this effect.


Asunto(s)
Apiaceae/química , Medicamentos Herbarios Chinos/farmacología , Mucosa Intestinal/efectos de los fármacos , Angelica sinensis , Animales , División Celular/efectos de los fármacos , Células Cultivadas , ADN/biosíntesis , ADN/efectos de los fármacos , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/uso terapéutico , Eflornitina/farmacología , Inhibidores Enzimáticos/farmacología , Mucosa Intestinal/citología , Ornitina Descarboxilasa/efectos de los fármacos , Ornitina Descarboxilasa/metabolismo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Proteínas Proto-Oncogénicas c-myc/metabolismo , Ratas , Ratas Wistar , Úlcera Gástrica/tratamiento farmacológico , Timidina/metabolismo , Tritio , Cicatrización de Heridas/efectos de los fármacos
3.
Life Sci ; 68(8): 961-8, 2001 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-11213366

RESUMEN

A crude extract from Angelica sinensis (ASCE), which mainly consists of polysaccharides, prevents ethanol- or indomethacin-induced gastric mucosal damage and promotes ulcer healing. The aim of this study was to test the hypothesis that ASCE has a direct stimulating effect on gastric epithelial cells for wound healing. We found that ASCE significantly promoted the migration of epithelial cells over an artificial wound on the surface of an RGM-1 monolayer. The extract also stimulated DNA synthesis in a dose-dependent manner and concomitantly increased EGF mRNA expression. Co-incubation of ASCE with anti-EGF antibody reduced the speed of migration and the DNA synthesis, which however were still higher than the control without ASCE. These results strongly suggest that ASCE has a direct wound healing effect on gastric mucosa, and this is acting partially through an EGF-mediated pathway.


Asunto(s)
Movimiento Celular/efectos de los fármacos , Mucosa Gástrica/efectos de los fármacos , Fármacos Gastrointestinales/farmacología , Plantas Medicinales/química , Polisacáridos/farmacología , Cicatrización de Heridas/efectos de los fármacos , Animales , Anticuerpos/farmacología , Técnicas de Cultivo de Célula , División Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Factor de Crecimiento Epidérmico/inmunología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Extractos Vegetales/farmacología , Raíces de Plantas/química , ARN Mensajero/biosíntesis , Úlcera Gástrica/tratamiento farmacológico , Úlcera Gástrica/patología , Timidina/metabolismo
4.
Life Sci ; 72(8): 925-32, 2003 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-12493573

RESUMEN

Our previous study showed that a crude extract from Angelica sinensis (ASCE), which mainly consisted of polysaccharides, significantly promoted migration and proliferation of normal gastric epithelial cells. These results strongly suggest that ASCE has a direct wound healing effect on gastric mucosa. However, there is no report concerning the effect of ASCE on gastric ulcer healing in animal models. In this study, we found that ASCE promoted ulcer healing. The area of the ulcer was reduced. This was accompanied with a significant increase in mucus synthesis when compared with the control. Angiogenesis was inhibited by the treatment of ASCE. Cell proliferation, ODC and EGFR protein expression was not affected in this process. Thus, the mechanism of how ASCE accelerates ulcer healing in addition to its effect on mucus synthesis remains to be investigated.


Asunto(s)
Antiulcerosos/uso terapéutico , Medicamentos Herbarios Chinos/uso terapéutico , Polisacáridos/uso terapéutico , Úlcera Gástrica/tratamiento farmacológico , Angelica sinensis , Inhibidores de la Angiogénesis/uso terapéutico , Animales , Antiulcerosos/aislamiento & purificación , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/química , Receptores ErbB/metabolismo , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Masculino , Moco/metabolismo , Neovascularización Patológica/patología , Ornitina Descarboxilasa/metabolismo , Polisacáridos/aislamiento & purificación , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Sprague-Dawley , Úlcera Gástrica/metabolismo , Úlcera Gástrica/patología , Cicatrización de Heridas/efectos de los fármacos
5.
Life Sci ; 69(6): 637-46, 2001 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-11476185

RESUMEN

A polysaccharides-enriched fraction from the root of Angelica sinensis, which is known for its antiulcer action on the gastrointestinal tract, was isolated and studied for its hepato-protective effect in rodents. Intra-gastric administration of Angelica sinensis polysaccharides-enriched fraction (AP) at the doses of 50 or 75 mg/kg dose-dependently prevented liver toxicity induced by acetaminophen in mice but did not affect the serum acetaminophen concentration. It normalized the rises of serum alanine transferase (ALT) and hepatic nitric oxide synthase (NOS) activities and the decrease of glutathione level in the liver. It also reduced the hepatic malondialdehyde (MDA) concentration. The protective effect was less evident in the carbon tetrachloride (CCl4)-treated animals including mice and rats. In the rat the elevated serum ALT level was unaffected though the MDA level was similarly reduced by the higher dose of AP. In these animals, CCl4 increased the hepatic glutathione level instead while the NOS activity remained unchanged. These findings suggest that the pathogenic mechanisms of both acetaminophen and CCl4 are different. AP is more effective in the protection against liver damage induced by acetaminophen, which is associated with the glutathione depletion and nitric oxide synthase activation in the liver.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Medicamentos Herbarios Chinos , Extractos Vegetales/uso terapéutico , Acetaminofén/sangre , Acetaminofén/toxicidad , Administración Oral , Alanina Transaminasa/sangre , Animales , Tetracloruro de Carbono/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Glicosaminoglicanos/uso terapéutico , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Malondialdehído/metabolismo , Ratones , Ratones Endogámicos ICR , Óxido Nítrico Sintasa/sangre , Óxido Nítrico Sintasa de Tipo II , Raíces de Plantas/química , Ratas , Ratas Sprague-Dawley
6.
Carcinogenesis ; 26(4): 827-34, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15637091

RESUMEN

Previous studies indicate that the arachidonic acid-metabolizing enzymes COX-2 and 5-LOX are overexpressed during the process of colonic adenoma formation promoted by cigarette smoke. The aims of the present study were to investigate whether there exists a relationship between COX-2 and 5-LOX, and whether dual inhibition of COX-2 and 5-LOX has an anticarcinogenic effect in the colonic tumorigenesis promoted by cigarette smoke. Results showed that pretreating colon cancer cells with cigarette smoke extract (CSE) promoted colon cancer growth in the nude mouse xenograft model. Inhibition of COX-2 or 5-LOX reduced the tumor size. In the group treated with COX-2-inhibitor, the PGE2 level decreased while the LTB4 level increased. In contrast, in the 5-LOX-inhibitor treated group, the LTB4 level was reduced and the PGE2 level was unchanged. However, combined treatment with both COX-2 and 5-LOX inhibitors further inhibited the tumor growth promoted by CSE over treatment with either COX-2-inhibitor or 5-LOX-inhibitor alone. This was accompanied by the downregulation of PGE2 and LTB4. In an in vitro study, we found that the action of CSE on colon cancer cells was mediated by 5-LOX DNA demethylation. In summary, these results indicate that inhibition of COX-2 may lead to a shunt of arachidonic acid metabolism towards the leukotriene pathway during colonic tumorigenesis promoted by CSE. Suppression of 5-LOX did not induce such a shunt and produced a better response. Therefore, 5-LOX inhibitor is more effective than COX-2 inhibitor, and blocker of both COX-2 and 5-LOX may present a superior anticancer profile in cigarette smokers.


Asunto(s)
Adenocarcinoma/prevención & control , Neoplasias del Colon/prevención & control , Inhibidores de la Ciclooxigenasa/uso terapéutico , Inhibidores de la Lipooxigenasa/uso terapéutico , Prostaglandina-Endoperóxido Sintasas/efectos de los fármacos , Adenocarcinoma/enzimología , Adenocarcinoma/etiología , Animales , Apoptosis/efectos de los fármacos , Araquidonato 5-Lipooxigenasa/genética , Araquidonato 5-Lipooxigenasa/metabolismo , Proliferación Celular/efectos de los fármacos , Neoplasias del Colon/enzimología , Neoplasias del Colon/etiología , Ciclooxigenasa 2 , Inhibidores de la Ciclooxigenasa 2 , Metilación de ADN , Dinoprostona/metabolismo , Femenino , Leucotrieno B4/metabolismo , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Neovascularización Patológica/prevención & control , Prostaglandina-Endoperóxido Sintasas/genética , Prostaglandina-Endoperóxido Sintasas/metabolismo , ARN Mensajero/metabolismo , Humo/efectos adversos , Nicotiana , Células Tumorales Cultivadas
7.
Am J Physiol Gastrointest Liver Physiol ; 281(2): G586-94, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11447040

RESUMEN

Preliminary studies showed that the inducible form of heme oxygenase (HO-1) was induced and played a protective role in the process of inflammation. The present study investigated the possible role of HO-1 in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats. We measured HO-1 activity in TNBS-induced colitis in rats and analyzed the severity of colitis along with altered HO activity by assessing lesion area and myeloperoxidase activity. HO-1 mRNA and protein expressions were determined at different time points after TNBS induction. Free radical production and inducible nitric oxide synthase (iNOS), which participate in oxidative injury, were also assayed. HO activity and HO-1 gene expression increased markedly after TNBS induction. Administration with tin mesoporphyrin (SnMP), a HO inhibitor, potentiated the colonic damage along with a reduction in HO-1 activity. Furthermore, the reduction of HO-1 expression by SnMP also enhanced reactive oxygen species and iNOS expression, both of which were dramatically increased after the TNBS enema. L-Arginine pretreatment further aggravated the injurious action of SnMP. Our results indicate that HO-1 plays a protective role in the colonic damage induced by the TNBS enema, and the preventive effects probably result from decreased free radical production and inhibition of iNOS expression in colonic tissues.


Asunto(s)
Colitis Ulcerosa/enzimología , Hemo Oxigenasa (Desciclizante)/fisiología , Animales , Colitis Ulcerosa/inducido químicamente , Colitis Ulcerosa/patología , Inhibidores Enzimáticos/farmacología , Hemo Oxigenasa (Desciclizante)/biosíntesis , Hemo Oxigenasa (Desciclizante)/genética , Hemo Oxigenasa (Desciclizante)/inmunología , Hemo-Oxigenasa 1 , Inmunohistoquímica , Mediciones Luminiscentes , Masculino , Metaloporfirinas/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II , Peroxidasa/metabolismo , ARN Mensajero/biosíntesis , Ratas , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/metabolismo , Ácido Trinitrobencenosulfónico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA